Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-vpsfw Total loading time: 0 Render date: 2024-07-19T09:42:17.974Z Has data issue: false hasContentIssue false

37 - Serious infections caused by typical bacteria

from Part V - Infectious problems in pediatric HIV disease

Published online by Cambridge University Press:  03 February 2010

Shirley Jankelevich
Affiliation:
Medical Officer, Pediatric Medicine Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD
Steven L. Zeichner
Affiliation:
National Cancer Institute, Bethesda, Maryland
Jennifer S. Read
Affiliation:
National Cancer Institute, Bethesda, Maryland
Get access

Summary

Introduction

HIV-infected children are at risk for the same minor and serious bacterial infections that affect immunocompetent children, although they occur more frequently and may be more severe in HIV-infected children. Because of this increased risk, the US Centers for Disease Control and Prevention (CDC) added a new category of invasive bacterial infections to the list of pediatric AIDS-defining illnesses in 1987 [1].

Bacterial infections in HIV-infected children often present in a manner similar to HIV-uninfected children and respond to the same antibiotics, although disseminated infection or frequent recurrences are often seen in HIV-infected children. The differential diagnosis may be large because some of these infections can present in a manner similar to opportunistic and endemic infections, including those due to viruses, unusual bacteria, fungi, and parasites. In addition, bacteria that are unusual in the immunocompetent host may cause significant disease in immunosuppressed HIV-infected children (Tables 37.1 and 37.2).

Multiple immunologic abnormalities in HIV-infected children prevent these children from mounting a robust immune response to a broad range of bacterial pathogens (See Chapter 3). These abnormalities include defects in the cell-mediated (T cell) and the humoral (B cell) arms of the immune system, decreases in neutrophil number, multiple defects in neutrophil function, impairment in macrophage and monocyte function [2], functional asplenia [3] and defects in three components of complement [3] (Table 37.1).

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Center for Disease Control and Prevention. Revised Classification System for Human Immunodeficiency Virus Infection in Children Less Than 13 Years of Age. Vol. 43 (1994), Relative Risk-12
Chaisson, R. E.Infections due to encapsulated bacteria, Salmonella, Shigella, and Campylobacter. Infect. Dis. Clin. N. Am. 2: 2 (1988), 475–84Google ScholarPubMed
Krasinski, K. Bacterial infections. In P. A. Pizzo (ed.), Acquired Immune Deficiency Syndrome. Baltimore: Williams & Wilkins (1994), pp. 241–53
Kovacs, A., Leaf, H. L. & Simberkoff, M. S.Bacterial infections. Med. Clin. N. Am. 81: 2 (1997), 319–43CrossRefGoogle ScholarPubMed
Pizzo, P. A. & Wilfert, C. M. (eds.), Pediatric Acquired Immune Deficiency Syndrome: the Challenge of Human Immunodeficiency Virus Infection in Infants, Children and Adolscents (3rd edn). Baltimore: Williams & Wilkins (1998)
Cruciani, M., Luzzati, R., Fioredda, F.. Mucosal colonization by pyogenic bacteria among children with Human Immunodeficiency Virus infection. Acquired Immune Deficiency Syndrome 7: 11 (1993), 1533–4Google Scholar
Gibb, D., Spoulou, V., Giacomelli, A.. Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection. Pediatr. Infect. Dis. J. 14: 2 (1995), 129–35CrossRefGoogle ScholarPubMed
King, J. C. Jr., Vink, P. E., Farley, J. J., Smilie, M., Parks, M. & Lichenstein, R.Safety and immunogenicity of three doses of a five-valent pneumococcal conjugate vaccine in children younger than two years with and without human immunodeficiency virus infection. Pediatrics 99: 4 (1997), 575–80CrossRefGoogle ScholarPubMed
Martino, M., Podda, A., Galli, L.. Acellular pertussis vaccine in children with perinatal human immunodeficiency virus-type 1 infection. Vaccine 15: 11 (1997), 1235–8CrossRefGoogle ScholarPubMed
Barbi, M., Biffi, M. R., Binda, S.. Immunization in children with Human Immunodeficiency Virus seropositivity at birth: antibody response to polio vaccine and tetanus toxoid. Acquired Immune Deficiency Syndrome 6: 12 (1992), 1465–9Google ScholarPubMed
Dankner, W. M., Lindsey, J. C. & Levin, M. J.Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. The Pediatric Acquired Immune Deficiency Syndrome Clinical Trials Group. Pediatr. Infect. Dis. J. 20: 1 (2001), 40–8CrossRefGoogle Scholar
Spector, S. A., Gelber, R. D., McGrath, N.. Intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. New Engl. J. Med. 331 (1994), 1181–7CrossRefGoogle ScholarPubMed
National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. New Engl. J. Med. 325 (1991), 73–80CrossRef
Westwood, A. T., Eley, B. S., Gilbert, R. D. & Hanslo, D.Bacterial infection in children with Human Immunodeficiency Virus: a prospective study from Cape Town, South Africa. Ann. Trop. Paediatr. 20: 3 (2000), 193–8CrossRefGoogle ScholarPubMed
World Heath Organization. World Health Organization Global Strategy for Containment of Antimicrobial Resistance. In World Health Organization/CDS/CRS/ DRS/2001.2; 2001
Feikin, D. R., Dowell, S. F., Nwanyanwu, O. C.. Increased carriage of trimethoprim/ sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/ pyrimethamine. J. Infect. Dis. 181: 4 (2000), 1501–5CrossRefGoogle ScholarPubMed
Whitney, C. G., Farley, M. M., Hadler, J.. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. New Engl. J. Med. 343: 26 (2000), 1917–24CrossRefGoogle ScholarPubMed
Henriques, Normark B., Novak, R., Ortqvist, A., Kallenius, G., Tuomanen, E. & Normark, S.Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin. Infect. Dis. 32: 4 (2001), 552–8Google Scholar
Nuorti, J. P., Butler, J. C., Gelling, L., Kool, J. L., Reingold, A. L. & Vugia, D. J.Epidemiologic relation between Human Immunodeficiency Virus and invasive pneumococcal disease in San Francisco County, California. Ann. Intern. Med. 132: 3 (2000), 182–90CrossRefGoogle Scholar
Rowland, K. E. & Turnidge, J. D.The impact of penicillin resistance on the outcome of invasive Streptococcus pneumoniae infection in children. Austr. N. Z. J. Med. 30 (2000), 441–9CrossRefGoogle ScholarPubMed
Huovinen, P.Resistance to trimethoprim-sulfamethoxazole. Clin. Infect. Dis. 32: 11 (2001), 1608–14Google ScholarPubMed
Martin, J. N., Rose, D. A., Hadley, W. K., Perdreau-Remington, F., Lam, P. K. & Gerberding, J. L.Emergence of trimethoprim-sulfamethoxazole resistance in the Acquired Immune Deficiency Syndrome era. J. Infect. Dis. 180: 6 (1999), 1809–18CrossRefGoogle Scholar
Klugman, K. P.Emerging infectious diseases — South Africa. Emerg. Infect. Dis. 4: 4 (1998), 517–520CrossRefGoogle ScholarPubMed
Kurien, T. L.Invasive Bacterial Infection Surveillance Group, International Clinical Epidemiology Network. Prospective multicenter hospital survellance of Streptococcus pneumoniae disease in India. Lancet 353 (1999), 1216–21Google Scholar
Leach, A. J., Shelby-James, T. M., Mayo, M.. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin. Infect. Dis. 24 (1997), 356–62CrossRefGoogle ScholarPubMed
Sack, R. B., Rahman, M., Yunus, M. & Khan, E. H.Antimicrobial resistance in organisms causing diarrheal disease. Clin. Infect. Dis. 24: Suppl. 1 (1997), S102–5CrossRefGoogle ScholarPubMed
Tee, W., Mijch, A., Wright, E. & Yung, A.Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus. Clin. Infect. Dis. 21 (1995), 634–8CrossRefGoogle ScholarPubMed
Shapiro, R. L., Kumar, L., Phillips-Howard, P.. Antimicrobial-resistant bacterial diarrhea in rural western Kenya. J. Infect. Dis. 183: 11 (2001), 1701–4CrossRefGoogle ScholarPubMed
Jones, R. N.Resistance patterns among nosocomial pathogens. Chest 2 (2001), 397S–404SCrossRefGoogle Scholar
Steinhoff, M.Invasive Haemophilus influenzae disease in India: a preliminary report of prospective multihospital surveillance. IBIS (Invasive Bacterial Infections Surveillance) Group. Pediatr. Infect. Dis. J. 17: Suppl. 9 (1998), 172–5Google ScholarPubMed
Madhi, S. A., Petersen, K., Madhi, A., Khoosal, M. & Klugman, K. P.Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin. Infect. Dis. 31: 1 (2000), 170–6CrossRefGoogle ScholarPubMed
Tacconelli, E., Tumbarello, M., Ventura, G., Lucia, M. B., Caponera, S. & Cauda, R.Drug resistant Pseudomonas aeruginosa bacteremia in Human Immunodeficiency Virus-infected patients. J. Chemother. 7: Suppl. 4 (1995), 180–3Google Scholar
Ruiz-Contreras, J., Ramos, J. T., Hernandez-Sampelayo, T.. Sepsis in children with human immunodeficiency virus infection. The Madrid Human Immunodeficiency Virus Pediatric Infection Collaborative Study Group. Pediatr. Infect. Dis. J. 14: 6 (1995), 522–6CrossRefGoogle ScholarPubMed
Moa, C., Harper, M., McIntosh, K.. Invasive pneumococcal infections in Human Immunodeficiency Virus—infected children. J. Infect. Dis. 173 (1995), 870–6Google Scholar
Rubinstein, A.Pediatric Acquired Immune Deficiency Syndrome. Curr. Probl. Pediatr. 16: 7 (1986), 361–409Google Scholar
Jacobs, J. L., Gold, J. W., Murray, H. W., Roberts, R. B. & Armstrong, D.Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med. 102: 2 (1985), 186–8CrossRefGoogle ScholarPubMed
Committee on Infectious Diseases. 2000 Red Book: Report of the Committee on Infectious Diseases, 25th edition. Elk Grove Village, Interleukin: American Academy of Pediatrics (2000)
Roilides, E., Marshall, D., Venzon, D., Butler, K., Husson, R. & Pizzo, P. A.Bacterial infections in human immunodeficiency virus type 1-infected children: the impact of central venous catheters and antiretroviral agents. Pediatr. Infect. Dis. J. 10: 11 (1991), 813–19CrossRefGoogle ScholarPubMed
Roilides, E., Butler, K. M., Husson, R. N., Mueller, B. U., Lewis, L. L. & Pizzo, P. A.Pseudomonas infections in children with human immunodeficiency virus infection. Pediatr. Infect. Dis. J. 11: 7 (1992), 547–53CrossRefGoogle ScholarPubMed
Mendelson, M. H., Gurtman, A., Szabo, S.. Pseudomonas aeruginosa bacteremia in patients with Acquired Immune Deficiency Syndrome. Clin. Infect. Dis. 18: 6 (1994), 886–95CrossRefGoogle Scholar
Geusau, A. & Tschacler, E.Human Immunodeficiency Virus-related skin disease. J. Royal Coll. Physicians Lond. 31 (1997), 374–9Google Scholar
Johann-Liang, R., Cervia, J. S. & Noel, G. J.Characteristics of human immunodeficiency virus-infected children at the time of death: an experience in the 1990s. Pediatr. Infect. Dis. J. 16 (1997), 1145–50CrossRefGoogle ScholarPubMed
Ruiz-Contreras, J., Ramos, J. T., Hernandez-Sampelayo, T., Jose, M., Clemente, J. & Gurbindo, M. D.Campylobacter sepsis in human immunodeficiency virus-infected children. The Madrid Human Immunodeficiency Virus Pediatric Infection Collaborative Study Group. Pediatr. Infect. Dis. J. 16: 2 (1997), 251–3CrossRefGoogle ScholarPubMed
Cotton, D. J., Gill, V. J., Marshall, D. J., Gress, J., Thaler, M. & Pizzo, P. A.Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population. J. Clin. Microbiol. 25: 4 (1987), 672–4Google Scholar
Sheikh, S., Madiraju, K., Steiner, P. & Rao, M.Bronchiectasis in pediatric Acquired Immune Deficiency Syndrome. Chest 112: 5 (1997), 1202–7CrossRefGoogle Scholar
Gallant, J. E. & Ko, A. H.Cavitary pulmonary lesions in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 22: 4 (1996), 671–82CrossRefGoogle ScholarPubMed
Izraeli, S., Mueller, B. U., Ling, A.. Role of tissue diagnosis in pulmonary involvement in pediatric human immunodeficiency virus infection. Pediatr. Infect. Dis. J. 15 (1996), 112–16CrossRefGoogle ScholarPubMed
Baron, A. D. & Hollander, H.Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease. Am. Rev. Respir. Dis. 148: 4 (1993), 992–6CrossRefGoogle ScholarPubMed
Spach, D. H. & Jackson, L. A.Bacterial meningitis. Neurol. Clin. 17: 4 (1999), 711–35CrossRefGoogle ScholarPubMed
Bernstein, L. J., Krieger, B. Z., Novick, B., Sicklick, M. J. & Rubinstein, A.Bacterial infection in the acquired immunodeficiency syndrome of children. Pediatr. Infect. Dis. 4: 5 (1985), 472–5CrossRefGoogle ScholarPubMed
Krasinski, K., Borkowsky, W., Bonk, S., Lawrence, R. & Chandwani, S.Bacterial infections in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 7: 5 (1988), 323–8CrossRefGoogle ScholarPubMed
Brown, P. D., Freeman, A. & Foxman, B.Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin. Infect. Dis. 34: 8 (2002), 1061–6CrossRefGoogle ScholarPubMed
Smith, K. J., Wagner, K. F., Yeager, J., Skelton, H. G. & Ledsky, R.Staphylococcus aureus carriage and Human Immunodeficiency Virus-1 disease: association with increased mucocutaneous infections as well as deep soft-tissue infections and sepsis. Arch. Dermatol. 130 (1994), 521–2CrossRefGoogle ScholarPubMed
Flores, G., Stavola, J. J. & Noel, G. J.Bacteremia due to Pseudomonas aeruginosa in children with Acquired Immune Deficiency Syndrome. Clin. Infect. Dis. 16: 5 (1993), 706–8CrossRefGoogle Scholar
Arditi, M. & Yogev, R.Perirectal abscess in infants and children: report of 52 cases and review of literature. Pediatr. Infect. Dis. J. 9 (1990), 411–15CrossRefGoogle ScholarPubMed
Shaked, A., Shinar, E. & Fruend, H.Managing the granulocytopenic patient with acute perianal inflammatory disease. Am. J. Surg. 152 (1986), 510–12CrossRefGoogle ScholarPubMed
Gilbert, M. S., Aledort, L. M., Seremetis, S., Needleman, B., Oloumi, G. & Forster, A.Long term evaluation of septic arthritis in hemophilic patients. Clin. Orthop.Jul: 328 (1996), 54–9CrossRefGoogle Scholar
Lambert, J. S., Stephens, I., Christy, C., Abramowicz, J. S. & Woodin, K. A.Human Immunodeficiency Virus and syphilis: maternal and fetal considerations. Pediatr. Acquired Immune Deficiency Syndrome Human Immunodeficiency Virus Infect. Fetus Adolesc. 6 (1995), 138–44Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×